New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 15, 2012
14:02 EDTAMED, HUMAmedisys sinks after warning new deal will generate less revenue
Home health care provider Amedisys (AMED) is tumbling after the company renewed its contract with health insurer Humana (HUM), but predicted that the new deal would generate 50% less revenue than the previous agreement. The new contract may cover fewer markets and Amedisys will be paid on a per visit basis, rather than on an episodic basis as was previously the case, Amedisys reported. Amedisys, which noted that it had previously generated $65M-$70M in revenue from Humana each year, said the new agreement would begin impacting its revenue this quarter. However, the "full impact" of the deal won't be felt until 2013, the home health care provider added. In mid-afternoon trading, Amedisys sank $1.39, or 10.43%, to $11.94.
News For AMED;HUM From The Last 14 Days
Check below for free stories on AMED;HUM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 16, 2014
16:27 EDTHUMOn The Fly: Closing Wrap
Subscribe for More Information
06:01 EDTHUMHumana announces $2B share repurchase authorization
Humana announced that its board has approved a $2B share repurchase authorization with an expiration date of December 31, 2016, replacing its previous $1B share repurchase authorization.
September 12, 2014
12:04 EDTHUMHumana management to meet with Jefferies
Subscribe for More Information
September 10, 2014
08:42 EDTHUMHumana says all 2015 Medicare Advantage, PDP offerings approved
Subscribe for More Information
September 5, 2014
07:56 EDTHUMHumana likely to add new growth drivers, says Wells Fargo
Subscribe for More Information
September 4, 2014
12:49 EDTHUMJudges to revisit ObamaCare subsidies decision, The Hill reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use